Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gynecology
  3. Microbiota, a source of early markers for gestational diabetes
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gynecology
  3. Microbiota, a source of early markers for gestational diabetes
Gynecology

Microbiota, a source of early markers for gestational diabetes

Diabetes
Gynecology Gastroenterology

The microbiota of women suffering from gestational diabetes has a very specific signature from the first trimester. This signature may be involved in the pathogenesis of the disorder, thus opening the door to more efficient diagnostic tools that detect the disease earlier. 1

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
Photo : Le microbiote, source de marqueurs précoces du diabète gestationnel

About this article

Created 05 April 2023
Updated 19 April 2023

Will it soon be possible to predict gestational diabetes (GDM) in the first trimester of pregnancy? So suggests a recent study published in the journal Gut.  

Israeli researchers recruited 394 women aged between 18 and 40 who were less than 3 months pregnant. The researchers collected stool samples to analyze their microbiota and blood samples to measure parameters such as blood glucose and serum cytokines. The researchers also recorded the participants’ medical history and dietary habits.

The participants were then followed for 27 to 30 weeks. In the second trimester, 44 of them (11%) developed GDM.
 

Clear differences in women with gestational diabetes

The results of the blood analyses showed that, as early as the first trimester, women who developed GDM had glucose intolerance and high levels of cytokines, particularly of interleukin-6 (IL-6), unlike the women without GDM. Several studies have shown that, by promoting inflammation, IL-6 is involved in various forms of diabetes, including GDM.

The analysis of the gut microbiota showed that as early as the first trimester women with GDM also presented:

  • A decrease in short-chain fatty acids (SCFAs), especially isovalerate and isoburate, which are known to improve insulin sensitivity and lower inflammatory responses;
  • A lower abundance of Prevotella, whose presence is associated with improved glucose metabolism;
  • An enrichment of certain metabolic pathways, such as mevalonate, which is associated with increased IL-6 levels.

Symptoms reproduced in mice through microbiota transplant

To find out whether these characteristics play a role in the pathogenesis of GDM, the researchers then transplanted the fecal microbiota (FMT) of the women in the study into germ-free mice (lacking microbiota). 

They observed the same symptoms in the FMT mice as in the women with GDM: glucose intolerance and higher levels of IL-6. This suggests that the microbiota may be involved in the pathogenesis of GDM. 

The results were the same for FMTs from pregnant women in two other cohorts from Finland and the US, suggesting the “universal” nature of the microbiota changes associated with GDM.

A global public health issue

Obesity has been on the rise in many countries since the mid-1970s, with excess weight being a major risk factor for gestational diabetes. The obesity “epidemic” has thus seen an increase in the number of women affected by this glucose metabolism disorder, as well as an increase in perinatal complications.

  • Today, on average, 10% of pregnant women are affected by gestational diabetes.
  • According to a meta-analysis published in 2022, the highest prevalences of gestational diabetes are found in North Africa and the Middle East (27.6%);
  • and in Southeast Asia (20.8%).
  • The lowest prevalences are in North America and the Caribbean (7.1%);
  • and in Europe (7.8%). 2

Towards new detection tools?

The researchers then used a prediction model to see which first trimester data (microbiome composition, cytokine profile, medical history, or dietary characteristics) most accurately predicted GDM. The results indicated that the model incorporating the medical record was the most accurate (odds ratio – OR – = 3.2), followed by the model based on the fecal microbiota. Using both models together, the OR increased to 4.
Although further studies are needed to determine whether dysbiosis is caused by diabetes or vice versa, these results suggest it may be possible to manage GDM from an earlier stage and, more importantly, to mitigate the adverse effects of the disorder on the health of mother and child.

Sources

1. Pinto Y, Frishman S, Turjeman S, Eshel A, et al. Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis. Gut. 2023 Jan 10:gutjnl-2022-328406.

2. Wang H, Li N, Chivese T, et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria. Diabetes Res Clin Pract. 2022 Jan;183:109050.

Tags
Diabetes Pregnancy Dysbiosis Glycemia

en_view en_sources

    See also

    Does a diverse microbiota lower the risk of diabetes?
    Diet, microbiota, and the immune system acting together in metabolic syndrome
    Created 05 April 2023
    Updated 19 April 2023

    About this article

    To know more about this topic.

    Main topic

    Diabetes

    Medical practice

    Gynecology Gastroenterology

    Content type

    News

    Continue reading

    News

    Oral microbiota and chronic conditions

    By Dr. Jay PatelUsher Institute of Population Health Sciences and Informatics, University of Edinburg...

    Find out more

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

    By Pr. Karine ClémentSorbonne University, Inserm, U...

    Find out more

    Vaginal Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Gut Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Highlights of Gut Microbiota for Health - World Summit 2023

    By Dr. Nicolas BenechGastroenterology and hepatology, Microbiota Study Group, Hospices Civils de Lyon...

    Find out more

    Rural environment reduces allergic inflammation by modulating the gut microbiota

    Commented article - Children's section By Pr. Emma...

    Find out more
    Everything you need to know about the microbiota gut-brain axis
    22.05.2023

    Everything you need to know about the microbiota gut-brain axis

    Read the article
    SII, microbiote intestinal et dépression : un triptyque pour mieux comprendre la maladie
    27.07.2022

    IBS, gut microbiota and depression: a trio shedding light on the disease

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

    By Pr. Karine ClémentSorbonne University, Inserm, U...

    Find out more

    Urinary and Urethral Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Vaginal Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo